Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Doximity (DOCS) Current Deferred Revenue (2020 - 2025)

Doximity has reported Current Deferred Revenue over the past 6 years, most recently at $66.3 million for Q4 2025.

  • Quarterly Current Deferred Revenue fell 4.18% to $66.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $66.3 million through Dec 2025, down 4.18% year-over-year, with the annual reading at $114.3 million for FY2025, 15.27% up from the prior year.
  • Current Deferred Revenue was $66.3 million for Q4 2025 at Doximity, down from $100.0 million in the prior quarter.
  • Over five years, Current Deferred Revenue peaked at $117.4 million in Q2 2025 and troughed at $65.6 million in Q4 2021.
  • The 5-year median for Current Deferred Revenue is $90.5 million (2022), against an average of $88.7 million.
  • Year-over-year, Current Deferred Revenue skyrocketed 87.26% in 2021 and then dropped 5.97% in 2024.
  • A 5-year view of Current Deferred Revenue shows it stood at $65.6 million in 2021, then grew by 6.24% to $69.7 million in 2022, then dropped by 4.27% to $66.7 million in 2023, then rose by 3.75% to $69.2 million in 2024, then decreased by 4.18% to $66.3 million in 2025.
  • Per Business Quant, the three most recent readings for DOCS's Current Deferred Revenue are $66.3 million (Q4 2025), $100.0 million (Q3 2025), and $117.4 million (Q2 2025).